These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1390486)

  • 1. Retinopathy of prematurity in surfactant treated infants.
    Rankin SJ; Tubman TR; Halliday HL; Johnston SS
    Br J Ophthalmol; 1992 Apr; 76(4):202-4. PubMed ID: 1390486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant replacement therapy and the prevalence of acute retinopathy of prematurity.
    Tubman TR; Rankin SJ; Halliday HL; Johnston SS
    Biol Neonate; 1992; 61 Suppl 1():54-8. PubMed ID: 1391267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bovine surfactant therapy and retinopathy of prematurity.
    McGinnity FG; Girschek PK; Morin JD; O'Donoghue EP; Dunn MS
    J Pediatr Ophthalmol Strabismus; 1994; 31(4):238-41. PubMed ID: 7807300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant replacement therapy: a new risk factor in developing retinopathy of prematurity?
    Termote JU; Schalij-Delfos NE; Wittebol-Post D; Brouwers HA; Hoogervorst BR; Cats BP
    Eur J Pediatr; 1994 Feb; 153(2):113-6. PubMed ID: 8157017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calf lung surfactant extract prophylaxis and retinopathy of prematurity.
    Repka MX; Hudak ML; Parsa CF; Tielsch JM
    Ophthalmology; 1992 Apr; 99(4):531-6. PubMed ID: 1584570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
    Jeon GW; Oh M; Sin JB
    Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for retinopathy of prematurity after surfactant treatment.
    Brunner-Di Pietro D; Bossi E; Koerner F
    Eur J Pediatr; 1995; 154(9 Suppl 4):S90-4. PubMed ID: 8529721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postnatal risk factors of retinopathy of prematurity.
    Kim TI; Sohn J; Pi SY; Yoon YH
    Paediatr Perinat Epidemiol; 2004 Mar; 18(2):130-4. PubMed ID: 14996252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinopathy of prematurity and surfactant treatment.
    Axer-Siegel R; Snir M; Ma'ayan A; Na'or N; Davidson S; Weinberger D; Yassur Y
    J Pediatr Ophthalmol Strabismus; 1996; 33(3):171-4. PubMed ID: 8771520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinopathy of prematurity: are we screening too many babies?
    Mathew MR; Fern AI; Hill R
    Eye (Lond); 2002 Sep; 16(5):538-42. PubMed ID: 12194065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized clinical trial of surfactant prophylaxis in retinopathy of prematurity.
    Holmes JM; Cronin CM; Squires P; Myers TF
    J Pediatr Ophthalmol Strabismus; 1994; 31(3):189-91. PubMed ID: 7931953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, randomized, double-blind trial of a new porcine surfactant in premature infants with respiratory distress syndrome.
    Rebello CM; Precioso AR; Mascaretti RS;
    Einstein (Sao Paulo); 2014; 12(4):397-404. PubMed ID: 25628188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant and ROP incidence.
    Rankin SJ; Tubman TR; Halliday HL; Johnston SS
    Ophthalmology; 1991 Aug; 98(8):1148-9. PubMed ID: 1923348
    [No Abstract]   [Full Text] [Related]  

  • 14. Surfactant prophylaxis and retinopathy of prematurity.
    Repka MX; Hardy RJ; Phelps DL; Summers CG
    Arch Ophthalmol; 1993 May; 111(5):618-20. PubMed ID: 8489440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect from surfactant therapy in extremely low birth weight infants depending on the method of delivery].
    Iarŭkova N; Nikolov A; Slŭncheva B; Vakrilova L; Pramatarova T; Dimitrov A
    Akush Ginekol (Sofiia); 2007; 46(3):31-5. PubMed ID: 18018780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriateness of surfactant dosing for preterm babies with respiratory distress syndrome: retrospective cohort study.
    Jourdain G; Zacaria F; Ammar F; De Luca D
    Arch Dis Child Fetal Neonatal Ed; 2016 Mar; 101(2):F182-3. PubMed ID: 26785859
    [No Abstract]   [Full Text] [Related]  

  • 17. Less severe retinopathy of prematurity induced by surfactant replacement therapy.
    Termote J; Schalij-Delfos NE; Cats BP; Wittebol-Post D; Hoogervorst BR; Brouwers HA
    Acta Paediatr; 1996 Dec; 85(12):1491-6. PubMed ID: 9001664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of the immediate response to surfactant.
    Kuint J; Reichman B; Neumann L; Shinwell ES
    Arch Dis Child Fetal Neonatal Ed; 1994 Nov; 71(3):F170-3. PubMed ID: 7820711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe retinopathy of prematurity in extremely low birth weight infants after short-term dexamethasone therapy.
    Ramanathan R; Siassi B; deLemos RA
    J Perinatol; 1995; 15(3):178-82; quiz 183-4. PubMed ID: 7666264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of severe respiratory distress syndrome in the premature infant with natural surfactant].
    Speer CP; Harms K; Müller U; Schröter W; Curstedt T; Robertson B
    Monatsschr Kinderheilkd; 1988 Feb; 136(2):65-70. PubMed ID: 3130571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.